Report for Dejager S

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (8)

Title : Mechanisms of action of the dipeptidyl peptidase-4 inhibitor vildagliptin in humans - Ahren_2011_Diabetes.Obes.Metab_13_775
Author(s) : Ahren B , Schweizer A , Dejager S , Villhauer EB , Dunning BE , Foley JE
Ref : Diabetes Obes Metab , 13 :775 , 2011
Abstract : Ahren_2011_Diabetes.Obes.Metab_13_775
ESTHER : Ahren_2011_Diabetes.Obes.Metab_13_775
PubMedSearch : Ahren_2011_Diabetes.Obes.Metab_13_775
PubMedID: 21507182

Title : Role of vildagliptin in managing type 2 diabetes mellitus in the elderly - Halimi_2010_Curr.Med.Res.Opin_26_1647
Author(s) : Halimi S , Raccah D , Schweizer A , Dejager S
Ref : Curr Med Res Opin , 26 :1647 , 2010
Abstract : Halimi_2010_Curr.Med.Res.Opin_26_1647
ESTHER : Halimi_2010_Curr.Med.Res.Opin_26_1647
PubMedSearch : Halimi_2010_Curr.Med.Res.Opin_26_1647
PubMedID: 20441397

Title : Changes in prandial glucagon levels after a 2-year treatment with vildagliptin or glimepiride in patients with type 2 diabetes inadequately controlled with metformin monotherapy - Ahren_2010_Diabetes.Care_33_730
Author(s) : Ahren B , Foley JE , Ferrannini E , Matthews DR , Zinman B , Dejager S , Fonseca VA
Ref : Diabetes Care , 33 :730 , 2010
Abstract : Ahren_2010_Diabetes.Care_33_730
ESTHER : Ahren_2010_Diabetes.Care_33_730
PubMedSearch : Ahren_2010_Diabetes.Care_33_730
PubMedID: 20067974

Title : GLP-1: what is known, new and controversial in 2010? - Burcelin_2010_Diabetes.Metab_36_503
Author(s) : Burcelin R , Dejager S
Ref : Diabetes Metab , 36 :503 , 2010
Abstract : Burcelin_2010_Diabetes.Metab_36_503
ESTHER : Burcelin_2010_Diabetes.Metab_36_503
PubMedSearch : Burcelin_2010_Diabetes.Metab_36_503
PubMedID: 21075654

Title : Vildagliptin enhances islet responsiveness to both hyper- and hypoglycemia in patients with type 2 diabetes - Ahren_2009_J.Clin.Endocrinol.Metab_94_1236
Author(s) : Ahren B , Schweizer A , Dejager S , Dunning BE , Nilsson PM , Persson M , Foley JE
Ref : J Clinical Endocrinology Metab , 94 :1236 , 2009
Abstract : Ahren_2009_J.Clin.Endocrinol.Metab_94_1236
ESTHER : Ahren_2009_J.Clin.Endocrinol.Metab_94_1236
PubMedSearch : Ahren_2009_J.Clin.Endocrinol.Metab_94_1236
PubMedID: 19174497

Title : Combination treatment in the management of type 2 diabetes: focus on vildagliptin and metformin as a single tablet - Halimi_2008_Vasc.Health.Risk.Manag_4_481
Author(s) : Halimi S , Schweizer A , Minic B , Foley J , Dejager S
Ref : Vasc Health Risk Manag , 4 :481 , 2008
Abstract : Halimi_2008_Vasc.Health.Risk.Manag_4_481
ESTHER : Halimi_2008_Vasc.Health.Risk.Manag_4_481
PubMedSearch : Halimi_2008_Vasc.Health.Risk.Manag_4_481
PubMedID: 18827867

Title : Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes - Fonseca_2007_Diabetologia_50_1148
Author(s) : Fonseca V , Schweizer A , Albrecht D , Baron MA , Chang I , Dejager S
Ref : Diabetologia , 50 :1148 , 2007
Abstract : Fonseca_2007_Diabetologia_50_1148
ESTHER : Fonseca_2007_Diabetologia_50_1148
PubMedSearch : Fonseca_2007_Diabetologia_50_1148
PubMedID: 17387446

Title : Vildagliptin in combination with pioglitazone improves glycaemic control in patients with type 2 diabetes failing thiazolidinedione monotherapy: a randomized, placebo-controlled study - Garber_2007_Diabetes.Obes.Metab_9_166
Author(s) : Garber AJ , Schweizer A , Baron MA , Rochotte E , Dejager S
Ref : Diabetes Obes Metab , 9 :166 , 2007
Abstract : Garber_2007_Diabetes.Obes.Metab_9_166
ESTHER : Garber_2007_Diabetes.Obes.Metab_9_166
PubMedSearch : Garber_2007_Diabetes.Obes.Metab_9_166
PubMedID: 17300592